<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e>, a common cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> related <z:hpo ids='HP_0011420'>deaths</z:hpo> in both sexes in western population is often due to persistent <z:mp ids='MP_0003674'>oxidative stress</z:mp> leading to DNA damage </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="11" ids="22586">Antioxidants</z:chebi> scavenge free radicals and inhibit neoplastic process </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="28499">Kaempferol</z:chebi>, a <z:chebi fb="0" ids="5078">flavonol</z:chebi> widely distributed in tea, broccoli, grape fruit, brussels sprouts and apple, is claimed to have chemopreventive action in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of our study was to evaluate the effect of <z:chebi fb="0" ids="28499">kaempferol</z:chebi> on tissue <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> status in 1,2-dimethyl <z:chebi fb="0" ids="15571">hydrazine</z:chebi> induced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in male Wistar rats and to compare its efficacy with irinotecan </plain></SENT>
<SENT sid="4" pm="."><plain>Experimental <z:hpo ids='HP_0003003'>colon cancer</z:hpo> induced by 1,2-dimethyl <z:chebi fb="0" ids="15571">hydrazine</z:chebi> in rats mimic human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and therefore is an ideal model for chemoprevention studies </plain></SENT>
<SENT sid="5" pm="."><plain>The rats were divided into six groups </plain></SENT>
<SENT sid="6" pm="."><plain>Group 1 served as control </plain></SENT>
<SENT sid="7" pm="."><plain>Group 2 received 1,2-dimethyl <z:chebi fb="0" ids="15571">hydrazine</z:chebi> (20 mg/kg body weight) subcutaneously once a week for four weeks </plain></SENT>
<SENT sid="8" pm="."><plain>Group 3 received irinotecan (100 mg/kg body weight) intravenously once a week for four weeks with 1,2-dimethyl <z:chebi fb="0" ids="15571">hydrazine</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Groups 4 to 6 were given a daily oral dose of 50, 100, 200 mg/kg body weight of <z:chebi fb="0" ids="28499">kaempferol</z:chebi> with 1,2-dimethyl <z:chebi fb="0" ids="15571">hydrazine</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>The total study period was 16 weeks </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="0" ids="28499">Kaempferol</z:chebi> supplementation lowered 1,2-dimethyl <z:chebi fb="0" ids="15571">hydrazine</z:chebi> induced erythrocyte lysate and liver <z:chebi fb="0" ids="33202">thiobarbituric acid</z:chebi> reactive substances level and rejuvenated anti oxidant enzymes catalase, super <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> dismutase and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase </plain></SENT>
<SENT sid="12" pm="."><plain>The recovery of enzyme status was maximum at the dose of 200 mg/kg body weight and was comparable to irinotecan </plain></SENT>
<SENT sid="13" pm="."><plain>Our study reveals that <z:chebi fb="0" ids="28499">kaempferol</z:chebi> could be safely used as a chemopreventive agent in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>